Diridavumab Antibody

Diridavumab is a monoclonal antibody targeting the influenza hemagglutinin (HA) stalk. It functions by stabilizing the prefusion HA conformation, thereby blocking the low-pH-mediated membrane fusion in endosomes. This mechanism makes it a valuable research tool for studying H2 influenza virus pathogenesis and for developing therapeutic strategies in both in vitro and in vivo models.